These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10123271)

  • 21. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW; Keith TD; Foster MT
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost savings achieved through cephalosporin use review and restriction.
    Dzierba SH; Reilly RT; Caselnova DA
    Am J Hosp Pharm; 1986 Sep; 43(9):2194-7. PubMed ID: 3766571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
    Lucas LM; Gerrity MS; Anderson T
    Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-use review program for concurrent histamine H2-receptor antagonist-sucralfate therapy.
    Kane MP; Briceland LL; Garris RE; Favreau BN
    Am J Hosp Pharm; 1990 Sep; 47(9):2007-10. PubMed ID: 1977317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative evaluation of cimetidine and ranitidine.
    Zimmerman TW; Schenker S
    Ration Drug Ther; 1985 Apr; 19(4):1-7. PubMed ID: 2932770
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of i.v. cimetidine, ranitidine, and famotidine in 40 hospitals.
    Segal R; Russell WL; Oh T; Ben-Joseph R
    Am J Hosp Pharm; 1993 Oct; 50(10):2077-81. PubMed ID: 8238052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cephalosporin-use restrictions in teaching hospitals.
    McCloskey WW; Johnson PN; Jeffrey LP
    Am J Hosp Pharm; 1984 Nov; 41(11):2359-62. PubMed ID: 6507437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive therapeutic interchange program in a community hospital.
    Oh T; Franko TG
    Am J Hosp Pharm; 1991 Jul; 48(7):1471-7. PubMed ID: 1882876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefits of clinical pharmacy services in a community hospital.
    Williams LE
    Hosp Pharm; 1993 Aug; 28(8):759-63, 766-7. PubMed ID: 10127576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strengthening the formulary system by implementing a drug usage guidelines program.
    Huber SL; Patry RA; Hudson HD; Godwin HN
    Hosp Formul; 1984 Aug; 19(8):664-8. PubMed ID: 10267390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulary streamlining through therapeutic class review.
    Guerriero SE; Neff JL
    Hosp Pharm; 1995 Apr; 30(4):287-90. PubMed ID: 10141869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Criteria-based antimicrobial i.v. to oral conversion program.
    Okpara AU; Maswoswe JJ; Stewart K
    Formulary; 1995 Jun; 30(6):343-8. PubMed ID: 10144873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of a once-daily aminoglycoside program in a large community-teaching hospital.
    Nicolau DP; Belliveau PP; Nightingale CH; Quintiliani R; Freeman CD
    Hosp Pharm; 1995 Aug; 30(8):674-6, 679-80. PubMed ID: 10144645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost containment through P & T committee drug utilization review.
    Bender FH; DeMatteo CS
    Hosp Formul; 1984 Aug; 19(8):699-700, 705-7. PubMed ID: 10267391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of aminoglycoside-use restrictions on drug cost.
    DeTorres OH; White RE
    Am J Hosp Pharm; 1984 Jun; 41(6):1137-9. PubMed ID: 6430070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges of a P & T Committee in a community teaching hospital.
    Cooke DH; Kessler J
    Hosp Formul; 1990 Aug; 25(8):878-82, 886. PubMed ID: 10105706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoting the cost-effective utilization of cefoxitin with a drug use education program.
    Wein PJ; Hoffman RP
    Hosp Formul; 1987 Mar; 22(3):299-306. PubMed ID: 10312016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tri-hospital formulary management: a joint effort to standardize therapy and reduce costs.
    Kile DM; McGrath ME; Schindel LP
    Hosp Formul; 1987 Feb; 22(2):176, 178, 181. PubMed ID: 10280289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial formulary management: a case study in a teaching hospital.
    Wright DB
    Pharmacotherapy; 1991; 11(1 ( Pt 2)):27S-31S. PubMed ID: 2011570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiulcer prescribing program in a state correctional system.
    Keith MR; Cason DM; Helling DK
    Ann Pharmacother; 1994 Jun; 28(6):792-6. PubMed ID: 7919571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.